Journal of Cardiothoracic and Vascular Anesthesia
Volume 23, Issue 3 , Pages 324-329 , June 2009

A Phase II Multicenter Double-Blind Placebo-Controlled Study of Ethyl Pyruvate in High-Risk Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass

  • Elliott Bennett-Guerrero, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, NC
    • Corresponding Author InformationReprints not available. Address correspondence to Elliott Bennett-Guerrero, MD, Duke Clinical Research Institute, Duke University (DUMC Box 3094), Durham, NC 27710
    • ,
  • Madhav Swaminathan, MD

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • Alina M. Grigore, MD

      Affiliations

    • Baylor College of Medicine, Texas Heart Institute, St Luke's Episcopal Hospital, Houston, TX
    • ,
  • Gary W. Roach, MD

      Affiliations

    • Kaiser Permanente, San Francisco, CA
    • ,
  • Laura G. Aberle, BsPH

      Affiliations

    • Duke Clinical Research Institute, Durham, NC
    • ,
  • Jeffrey M. Johnston, MD

      Affiliations

    • Critical Therapeutics Inc, Lexington, MA
    • ,
  • Mitchell P. Fink, MD

      Affiliations

    • University of Pittsburgh, Pittsburgh, PA

References 

  1. Dobsak P, Courderot-Masuyer C, Zeller M, et al. Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia. J Cardiovasc Pharmacol. 1999;34:651–659
  2. Fink MP. Ringer's ethyl pyruvate solution: A novel resuscitation fluid. Minerva Anestesiol. 2001;67:190–192
  3. Fink MP. Reactive oxygen species as mediators of organ dysfunction caused by sepsis, acute respiratory distress syndrome, or hemorrhagic shock: Potential benefits of resuscitation with Ringer's ethyl pyruvate solution. Curr Opin Clin Nutr Metab Care. 2002;5:167–174
  4. Das UN. Pyruvate is an endogenous anti-inflammatory and anti-oxidant molecule. Med Sci Monit. 2006;12:RA79–RA84
  5. Fink MP. Ethyl pyruvate: A novel anti-inflammatory agent. J Intern Med. 2007;261:349–362
  6. Sims CA, Wattanasirichaigoon S, Menconi MJ, et al. Ringer's ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in rats. Crit Care Med. 2001;29:1513–1518
  7. Sappington PL, Fink ME, Yang R, et al. Ethyl pyruvate provides durable protection against inflammation-induced intestinal epithelial barrier dysfunction. Shock. 2003;20:521–528
  8. Sappington PL, Han X, Yang R, et al. Ethyl pyruvate ameliorates intestinal epithelial barrier dysfunction in endotoxemic mice and immunostimulated caco-2 enterocytic monolayers. J Pharmacol Exp Ther. 2003;304:464–476
  9. Song M, Kellum JA, Kaldas H, et al. Evidence that glutathione depletion is a mechanism responsible for the anti-inflammatory effects of ethyl pyruvate in cultured lipopolysaccharide-stimulated RAW 264.7 cells. J Pharmacol Exp Ther. 2004;308:307–316
  10. Ulloa L, Ochani M, Yang H, et al. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci U S A. 2002;99:12351–12356
  11. Woo YJ, Taylor MD, Cohen JE, et al. Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia. J Thorac Cardiovasc Surg. 2004;127:1262–1269
  12. Uchiyama T, Delude RL, Fink MP. Dose-dependent effects of ethyl pyruvate in mice subjected to mesenteric ischemia and reperfusion. Intensive Care Med. 2003;29:2050–2058
  13. Tsung A, Kaizu T, Nakao A, et al. Ethyl pyruvate ameliorates liver ischemia-reperfusion injury by decreasing hepatic necrosis and apoptosis. Transplantation. 2005;79:196–204
  14. Venkataraman R, Kellum JA, Song M, et al. Resuscitation with Ringer's ethyl pyruvate solution prolongs survival and modulates plasma cytokine and nitrite/nitrate concentrations in a rat model of lipopolysaccharide-induced shock. Shock. 2002;18:507–512
  15. Tawadrous ZS, Delude RL, Fink MP. Resuscitation from hemorrhagic shock with Ringer's ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats. Shock. 2002;17:473–477
  16. Yang R, Gallo DJ, Baust JJ, et al. Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock. Am J Physiol Gastrointest Liver Physiol. 2002;283:G212–G221
  17. Su F, Wang Z, Cai Y, et al. Beneficial effects of ethyl pyruvate in septic shock from peritonitis. Arch Surg. 2007;142:166–171
  18. Kim JB, Yu YM, Kim SW, et al. Anti-inflammatory mechanism is involved in ethyl pyruvate-mediated efficacious neuroprotection in the postischemic brain. Brain Res. 2005;1060:188–192
  19. Yu YM, Kim JB, Lee KW, et al. Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window. Stroke. 2005;36:2238–2243
  20. Yang R, Uchiyama T, Alber SM, et al. Ethyl pyruvate ameliorates distant organ injury in a murine model of acute necrotizing pancreatitis. Crit Care Med. 2004;32:1453–1459
  21. Dong YQ, Yao YM, Wei P, et al. [Effects of ethyl pyruvate on cell-mediated immune function in rats with delayed resuscitation after burn injury.]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2005;17:12–15
  22. Epperly M, Jin S, Nie S, et al. Ethyl pyruvate, a potentially effective mitigator of damage after total-body irradiation. Radiat Res. 2007;168:552–559
  23. Reade MC, Fink MP. Bench-to-bedside review: Amelioration of acute renal impairment using ethyl pyruvate. Crit Care. 2005;9:556–560
  24. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest. 1997;112:676–692
  25. Cheng BQ, Liu CT, Li WJ, et al. Ethyl pyruvate improves survival and ameliorates distant organ injury in rats with severe acute pancreatitis. Pancreas. 2007;35:256–261
  26. Fink MP. Ringer's ethyl pyruvate solution: A novel resuscitation fluid for the treatment of hemorrhagic shock and sepsis. J Trauma. 2003;54:S141–S143
  27. Miyaji T, Hu X, Yuen PS, et al. Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice. Kidney Int. 2003;64:1620–1631
  28. Yang R, Han X, Delude RL, et al. Ethyl pyruvate ameliorates acute alcohol-induced liver injury and inflammation in mice. J Lab Clin Med. 2003;142:322–331
  29. Yang R, Uchiyama T, Watkins SK, et al. Ethyl pyruvate reduces liver injury in a murine model of extrahepatic cholestasis. Shock. 2004;22:369–375
  30. Parsonnet V, Dean D, Bernstein AD. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation. 1989;79:I3–I12
  31. Bellomo R, Kellum JA, Ronco C. Defining and classifying acute renal failure: From advocacy to consensus and validation of the RIFLE criteria. Intensive Care Med. 2007;33:409–413
  32. Joulin O, Petillot P, Labalette M, et al. Cytokine profile of human septic shock serum inducing cardiomyocyte contractile dysfunction. Physiol Res. 2007;56:291–297
  33. Carsin H, Assicot M, Feger F, et al. Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF alpha and endotoxin levels early after thermal injury. Burns. 1997;23:218–224
  34. Rasmussen BS, Sollid J, Knudsen L, et al. The release of systemic inflammatory mediators is independent of cardiopulmonary bypass temperature. J Cardiothorac Vasc Anesth. 2007;21:191–196
  35. Presterl E, Staudinger T, Pettermann M, et al. Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis. Am J Respir Crit Care Med. 1997;156:825–832
  36. Wortel CH, van Deventer SJ, Aarden LA, et al. Interleukin-6 mediates host defense responses induced by abdominal surgery. Surgery. 1993;114:564–570

 Sponsored by Critical Therapeutics Inc, Lexington, MA.

PII: S1053-0770(08)00237-1

doi: 10.1053/j.jvca.2008.08.005

Journal of Cardiothoracic and Vascular Anesthesia
Volume 23, Issue 3 , Pages 324-329 , June 2009

Article Tools